Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats

• Published in: World journal of gastroenterology : WJG 2013-05, Vol.19 (19), p.2894-2903
• Main Authors: Akyazi, Ibrahim, Eraslan, Evren, Gülçubuk, Ahmet, Ekiz, Elif Ergül, Cırakli, Zeynep L, Haktanir, Damla, Bala, Deniz Aktaran, Ozkurt, Mete, Matur, Erdal, Ozcan, Mukaddes
• Format: Article
• Language: English
• Subjects: Amylases - blood; Animals; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Antioxidants - metabolism; Aspirin - administration & dosage; Biomarkers - blood; Ceruletide; Disease Models, Animal; Drug Administration Schedule; Inflammation Mediators - blood; Lipase - blood; Lipid Peroxidation - drug effects; Male; Original; Oxidative Stress - drug effects; Pancreas - drug effects; Pancreas - metabolism; Pancreas - pathology; Pancreatitis - blood; Pancreatitis - chemically induced; Pancreatitis - pathology; Pancreatitis - prevention & control; Rats; Rats, Wistar; Time Factors
• ISSN: 1007-9327; 2219-2840
• DOI: 10.3748/wjg.v19.i19.2894

To investigate the effects of long term pretreatment with low-, medium- and high-dose aspirin (acetylsalicylic acid, ASA) on a model of acute pancreatitis (AP) induced in rats. Forty male Wistar rats were used. Three experimental groups, each consisting of eight animals, received low- (5 mg/kg per day), medium- (150 mg/kg per day) and high-dose (350 mg/kg per day) ASA in supplemented pellet chow for 100 d. Eight animals, serving as the AP-control group, and another eight, serving as reference value (RV) group, were fed with standard pellet chow for the same period. After pretreatment, AP was induced in the experimental animals by intraperitoneal administration of cerulein (2 × 50 μg/kg), while the RV group received saline in the same way. Twelve hours after the second injection, the animals were sacrificed. Pancreatic tissue and plasma samples were collected. One part of the collected pancreatic tissues was used for histopathological evaluation, and the remaining portion was homogenized. Cytokine levels [tumor necrosis factor, interleukin (IL)-1β, IL-6], hemogram parameters, biochemical parameters (amylase and lipase), nuclear factor-κB, aspirin triggered lipoxins and parameters related to the antioxidant system (malondialdehyde, nitric oxide, hemeoxygenase-1, catalase and superoxide dismutase) were measured. Cerulein administration induced mild pancreatitis, characterized by interstitial edema (total histopathological score of 5.88 ± 0.44 vs 0.25 ± 0.16, P < 0.001). Subsequent pancreatic tissue damage resulted in an increase in amylase (2829.71 ± 772.48 vs 984.57 ± 49.22 U/L, P = 0.001) and lipase (110.14 ± 75.84 U/L vs 4.71 ± 0.78 U/L, P < 0.001) in plasma, and leucocytes (6.89 ± 0.48 vs 4.36 ± 0.23, P = 0.001) in peripheral blood. Cytokines, IL-1β (18.81 ± 2.55 pg/μg vs 6.65 ± 0.24 pg/μg, P = 0.002) and IL-6 (14.62 ± 1.98 pg/μg vs 9.09 ± 1.36 pg/μg, P = 0.04) in pancreatic tissue also increased. Aspirin pretreatment reduced the increase in the aforementioned parameters to a certain degree and partially improved the histopathological alterations caused by cerulein. No evidence of side effects related to chronic ASA administration (e.g., inflammation or bleeding) was observed in the gastrointestinal tract in macroscopic and histopathological examination. Long term ASA pretreatment could prevent and/or ameliorate certain hematological, serological and histological alterations caused by cerulein-induced AP.